Published in Semin Thromb Hemost on April 13, 2010
Factor VII Deficiency. Semin Thromb Hemost (2009) 1.69
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med (2004) 3.74
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood (2002) 3.59
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med (2002) 3.51
An association between atherosclerosis and venous thrombosis. N Engl J Med (2003) 3.39
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. Blood (2002) 1.78
Pregnancy and oral contraceptives in factor V deficiency: a study of 22 patients (five homozygotes and 17 heterozygotes) and review of the literature. Haemophilia (2005) 1.48
Congenital factor X deficiencies with a defect only or predominantly in the extrinsic or in the intrinsic system: a critical evaluation. Am J Hematol (2008) 1.48
Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis. Thromb Haemost (2003) 1.46
Mild bleeding diathesis in a boy with combined severe haemophilia B (C(10400)-->T) and heterozygous factor V Leiden. Haemophilia (2001) 1.43
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. Eur J Med Genet (2010) 1.41
The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified. J Thromb Thrombolysis (2009) 1.38
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood (2002) 1.23
Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost (2006) 1.12
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab (2002) 1.10
Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood (2002) 1.02
Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A. J Hum Genet (2008) 1.01
The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. J Thromb Thrombolysis (2004) 1.01
Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. Thromb Haemost (2010) 0.98
The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ (2004) 0.96
Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats. Diabetes (2001) 0.96
C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost (2006) 0.95
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. Blood (2002) 0.93
Thrombosis-free surgical procedures in severe (Homozygote) factor XII deficiency: report of four additional cases and literature review. Clin Appl Thromb Hemost (2004) 0.93
The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost (2002) 0.93
Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle. Int J Obes Relat Metab Disord (2002) 0.93
Rebuttal: factor XII levels, factor XII 46 C>T polymorphism and venous thrombosis: a word of caution is needed. Thromb Haemost (2004) 0.92
Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases. J Thromb Thrombolysis (2006) 0.91
Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med (2002) 0.89
Leptin concentration in newborns' cord blood: relationship to gender and growth-regulating hormones. Int J Obes Relat Metab Disord (1999) 0.86
Myocardial infarction and arterial thrombosis in severe (homozygous) FXII deficiency: no apparent causative relation. Clin Appl Thromb Hemost (2005) 0.86
Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. Haematologica (2003) 0.86
Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol. Blood Coagul Fibrinolysis (2003) 0.84
The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost (2003) 0.84
Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. Haematologica (2005) 0.83
Does hemophilia protect against atherosclerosis? A case-control study. Clin Appl Thromb Hemost (2006) 0.83
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood (2002) 0.82
Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance. Thromb Haemost (2001) 0.82
Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis. Acta Haematol (2010) 0.82
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. Thromb Haemost (2004) 0.82
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. Blood (2002) 0.81
Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes. Blood Coagul Fibrinolysis (2008) 0.81
Leg ulcers in elderly on hydroxyurea: a single center experience in Ph- myeloproliferative disorders and review of literature. Aging Clin Exp Res (2006) 0.81
Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population. Thromb Haemost (2005) 0.81
Unexplained discrepancies in the activity--antigen ratio in congenital FX deficiencies with defects in the catalytic domain. Clin Appl Thromb Hemost (2009) 0.81
Lactate infusion in anesthetized rats produces insulin resistance in heart and skeletal muscles. Metabolism (1997) 0.81
JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia. Aging Clin Exp Res (2011) 0.80
Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era. Haemophilia (2011) 0.80
Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature. J Thromb Thrombolysis (2007) 0.80
A A386G biallelic GPIbα gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis. Haematologica (2011) 0.79
Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr). Thromb Haemost (2003) 0.79
A large family from Argentina with prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): prekallikrein Cordoba. Am J Hematol (2010) 0.79
Lactate infusion to normal rats during hyperglycemia enhances in vivo muscle glycogen synthesis. Am J Physiol (1997) 0.78
Influence of the Alu-repeat I/D polymorphism in t-PA gene intron 8 on the stimulated t-PA release after venous occlusion. Clin Appl Thromb Hemost (2003) 0.78
The lack of ties between north-eastern Italy and African-Americans suggest a multi-founder effect for FVII Padua (Arg304Gln) disorder. Blood Coagul Fibrinolysis (2010) 0.78
Substrate competition and insulin action in animal models. Int J Obes Relat Metab Disord (2000) 0.78
A case of Bernard-Soulier Syndrome due to a homozygous four bases deletion (TGAG) of GPIbalpha gene: lack of GPIbalpha but absence of bleeding. Platelets (2008) 0.78
Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. Clin Appl Thromb Hemost (2007) 0.78
FXII deficiency is neither a cause of thrombosis nor a protection from thrombosis. Am J Ophthalmol (2005) 0.78
Different genotypes are responsible for the normal Russell viper venom assays seen in some cases of congenital factor X deficiency. Am J Hematol (2008) 0.77
Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy. Transplantation (2003) 0.77
Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin. Hematology (2012) 0.77
The impact of blood coagulability on atherosclerosis and cardiovascular disease: a rebuttal. J Thromb Haemost (2013) 0.77
Efficacy of AT in pre-eclampsia: a case-control prospective trial. Thromb Haemost (2004) 0.77
Hyperinsulinism plus hyperammonemia. J Pediatr (1998) 0.76
Lipolytic effect of beta-endorphin in human fat cells. Life Sci (1993) 0.76
Are antiphospholipid antibodies an independent risk factor for atherosclerosis? Clin Appl Thromb Hemost (2002) 0.76
Comparable levels of activity and antigen in factor XII deficiency: a study of 21 homozygotes and 58 heterozygotes. Clin Appl Thromb Hemost (2005) 0.76
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP. Thromb Res (2010) 0.76
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. Blood Coagul Fibrinolysis (2014) 0.76
The spectrum of factor VII deficiencies and abnormalities. Blood Coagul Fibrinolysis (2004) 0.75
About the significance or the insignificance of the factor XII C46T polymorphism: a rebuttal. J Thromb Haemost (2007) 0.75
Selection of both normal and bleeding patients is indicated before desmopressin administration. Thromb Haemost (2005) 0.75
Different fatherhood as a possible explanation for difficult pedigrees in coagulation defects: only 'mater semper certa est'. Br J Haematol (2005) 0.75
Oral contraceptives, thrombosis and socio-ethical values: an inevitable compromise is needed based mainly on a careful evaluation of potential users. Clin Appl Thromb Hemost (2005) 0.75
Mutations are no substitutes for clotting, chromogenic and immunological assays in patients with congenital prothrombin deficiency. Am J Hematol (2008) 0.75
A comment about the correct attribution of the discovery of FX Friuli disorder. Clin Appl Thromb Hemost (2012) 0.75
Effect of lactate on hepatic insulin clearance in perfused rat liver. Am J Physiol (1996) 0.75
Haemostatic proteins gene polymorphisms in patients with unusual vein thrombosis and Ph-myeloproliferative disorders. Thromb Haemost (2007) 0.75
Confirmation of the value of a modified long-distance polymerase chain reaction in the detection of inversion intron 22 in severe hemophilia a: a technical note. Clin Appl Thromb Hemost (2005) 0.75
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors. Thromb Haemost (2003) 0.75
Hydroxyurea in old patients with essential thrombocythemia. Aging Clin Exp Res (2008) 0.75
Autosomal dominant macrothrombocytopenia with ineffective thrombopoiesis. Haematologica (2002) 0.75
Conformation sensitive gel electrophoresis for detection of factor X gene mutations. Thromb Res (2002) 0.75
Effect of delivery modalities on the physiologic inhibition system of coagulation of the neonate. Thromb Res (2002) 0.75
Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia. Thromb Haemost (2010) 0.75
A large deletion due to a new mutation (intron 13/exon 23) in a sporadic case of severe hemophilia A. Clin Appl Thromb Hemost (2004) 0.75
Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia. Haematologica (2002) 0.75
Thrombotic Events in Asymptomatic FXII Deficiency versus Symptomatic FXI Deficiency: Surprising Observations. Acta Haematol (2016) 0.75
Thrombocytosis and recurrent hepatic outflow obstruction (Budd-Chiari syndrome) after successful thrombolysis: case report and literature review. Clin Appl Thromb Hemost (2002) 0.75
Recent progress in the therapeutic management of pre-eclampsia. Expert Opin Pharmacother (2004) 0.75
Microsatellite alterations in uterine leiomyomas. Anticancer Res (1998) 0.75
Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE). Haematologica (2002) 0.75
Difficulties in the mutation analysis of plasminogen gene: a study in two patients with ligneous conjunctivitis. Clin Appl Thromb Hemost (2006) 0.75
[Epidemiology of syphilis: new cases of neurosyphilis]. Ann Ig (2012) 0.75
The clinical and laboratory significance of cases of congenital FX deficiency due to defects in the Gla-domain. Hematology (2009) 0.75
A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain. Blood Coagul Fibrinolysis (2003) 0.75